The Synthetic Biology Innovation Network

The Global
Synthetic Biology Summit

SVN West
San Francisco, California
Tuesday-Thursday, Oct. 1-3, 2019

The Global
Synthetic Biology Summit

SVN West
San Francisco, California
Tuesday-Thursday, Oct. 1-3, 2019

Stay updated on the latest news in synthetic biology with

How chemical-sensing plants may help secure a safe, healthy future

Raytheon is using synthetic biology to turn plants into a national security surveillance tool for innocuous detection of chemical and biological threats.

These 37 synthetic biology companies raised $1.2B this quarter

Crunchbase reports that startup funding is flat this quarter. But the synthetic biology industry doesn’t seem to have gotten the memo.

Protein design 101: An introduction to protein design for synthetic biology - with Alexandre Zanghellini

Alex will introduce protein design, discuss automation and technical advancement, touch on a few applications, and the potential of protein design to improve the world and bring new products to market.

Tackling the future of sustainability at the 2019 Biodesign Challenge Summit

Pseudofreeze designed a refrigeration system for transporting vaccines using a bacterium to keep the compartment cool.

Editors' picks

Synthetic biology news from the lab bench #4

Here’s our pick of the most interesting research news this week: Protein engineering 👩‍🔬This review by scientists at Caltech (including Nobel Laureate Frances Arnold, a keynote speaker at SynBioBeta 2019) covers basic...

How chemical-sensing plants may help secure a safe, healthy future

These 37 synthetic biology companies raised $1.2B this quarter

Crunchbase reports that startup funding is flat this quarter. But the synthetic biology industry doesn’t seem to have gotten the memo. SynBioBeta released its Synthetic Biology Investment Report for this quarter...

Protein design 101: An introduction to protein design for synthetic biology – with Alexandre Zanghellini

Tackling the future of sustainability at the 2019 Biodesign Challenge Summit

Microgravity: biomedicine’s next frontier

The space-lab is busy with activity. In one corner, a liquid handling robot methodically transfers solutions from one plate to another. In a different section, a plate reader measures enzyme activity of a cell culture...

Rethinking sustainable agriculture: creative solutions from unexpected places

Synthetic biology news from the lab bench #3

From more efficient CRISPR tools to (future) computers made with bacteria, it was another big week for synthetic biology research. Here’s the news you need to know: Agriculture 🌼Scientists have discovered a gene that...

How to tell your synthetic biology story – with Ben Kellogg of BWK (The SynBioBeta Podcast)

Synthetic biology news from the lab bench #2

View all posts

Press releases

MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation

– New framework simplifies and accelerates access to CRISPR intellectual property for research BURLINGTON, Mass. and CAMBRIDGE, Mass., July 18, 2019 /PRNewswire/ — MilliporeSigma and the Broad Institute of...

Ambrx to receive milestone payment from Bristol-Myers Squibb for the initiation of Phase 1 Clinical Trial of a long-acting Relaxin derivative

– Long acting Relaxin is powered by Ambrx technology SAN DIEGO, California, July 16, 2019 –Ambrx Inc, today announced that Bristol-Myers Squibb Company (“BMS”) has initiated a phase I clinical trial to evaluate...

Evogene Amends its Collaboration Agreement with Bayer to Include Genome Editing Targets

Amended agreement follows positive results in corn stalk rot fungal disease control Rehovot, Israel – July 16, 2019 – Evogene Ltd. (NASDAQ, TASE: EVGN) a leading biotechnology company developing novel products for life...

Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome

Ann Arbor, Michigan July 16, 2019 – Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for...

Cibus Issued New Patent For Increasing Efficiency Of Gene-Editing In Plants

— Further Extends Cibus Intellectual Property for its Precise Gene-Editing Technologies — SAN DIEGO, July 15, 2019 /PRNewswire/ — Cibus, a leader in advanced plant-breeding technologies, today...

University of California granted U.S. CRISPR-Cas9 patent related to production of genetically modified cells

Eighth patent in UC’s wide-ranging CRISPR-Cas9 portfolio involves introducing Cas9 into a cell for genome editing BERKELEY, Calif., July 16, 2019 /PRNewswire/ — The U.S. Patent and Trademark Office (USPTO)...

Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria and Guides to Next Phase of Development

– Data demonstrate statistically significant biomarker activity at well-tolerated dose in PKU patients – – Plan to initiate bridging study with new oral solid formulation in Q3 2019 – – Conference call and webcast...

Casebia Highlights Novel Research in Gene Editing Therapeutics for Hemophilia A

Early-stage animal model data presented during the ISTH 2019 Congress demonstrates ability to edit hepatocytes and accurately tune production of Factor VIII CAMBRIDGE, Mass.–(BUSINESS WIRE)–Casebia...

Braskem renews partnership with France-based startup specializing in development of microorganisms

In line with its commitment to sustainable development, Braskem, the world’s largest biopolymer producer, announces the renewal of its partnership with Altar, a France-based startup specializing in the development...

Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies

Funding Round led by Tuatara Capital with Continued Participation by Horizons Ventures EMERYVILLE, Calif., July 11, 2019 /PRNewswire/ — Today, Demetrix Inc., a biotechnology company focused on the production of...

BASF is collaborating with Riffyn on white biotechnology R&D

Next-generation global data platform to advance development of bio-based solutions and fermentation processes RESEARCH TRIANGLE PARK, NC, July 10, 2019 – To advance its development of bio-based solutions and...

DMC Biotechnologies, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners

[Boulder, CO] July 9, 2019 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a Series A equity financing led by Sofinnova Partners. The company also announced the addition...

Editors' picks

Synthetic biology news from the lab bench #4

How chemical-sensing plants may help secure a safe, healthy future

These 37 synthetic biology companies raised $1.2B this quarter

Protein design 101: An introduction to protein design for synthetic biology – with Alexandre Zanghellini

Tackling the future of sustainability at the 2019 Biodesign Challenge Summit

Microgravity: biomedicine’s next frontier

Rethinking sustainable agriculture: creative solutions from unexpected places

Synthetic biology news from the lab bench #3

How to tell your synthetic biology story – with Ben Kellogg of BWK (The SynBioBeta Podcast)

Synthetic biology news from the lab bench #2

Press releases

MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation

Ambrx to receive milestone payment from Bristol-Myers Squibb for the initiation of Phase 1 Clinical Trial of a long-acting Relaxin derivative

Evogene Amends its Collaboration Agreement with Bayer to Include Genome Editing Targets

Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome

Cibus Issued New Patent For Increasing Efficiency Of Gene-Editing In Plants

University of California granted U.S. CRISPR-Cas9 patent related to production of genetically modified cells

Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria and Guides to Next Phase of Development

Casebia Highlights Novel Research in Gene Editing Therapeutics for Hemophilia A

Braskem renews partnership with France-based startup specializing in development of microorganisms

Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies

BASF is collaborating with Riffyn on white biotechnology R&D

DMC Biotechnologies, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners

News by topic

Agriculture

Health and medicine

Funding & investments

Biomanufacturing, chemicals & materials

Emerging technologies

Food and nutrition

Consumer goods

Energy & environment

Policy & public